This latest twist during the Lykos Therapeutics saga threatens A serious overhaul of the business’s technique and course, with Musk ally and billionaire Trader Antonio Gracias appearing to need to acquire the organization back again towards its nonprofit drug enhancement roots and a more Doblinite philosophy.Among the crucial options with the Por